Molina Healthcare, Inc. (MOH) CEO Joe Zubretsky on Q2 2022 Results - Earnings Call Transcript

Molina Healthcare, Inc. (NYSE:MOH) Q2 2022 Earnings Conference Call July 28, 2022 8:00 AM ET

Company Participants

Joe Krocheski - Senior Vice President of Investor Relations

Joe Zubretsky - President and Chief Executive Officer

Mark Keim - Chief Financial Officer

Conference Call Participants

Josh Raskin - Nephron Research

Matthew Borsch - BMO Capital Markets

Stephen Baxter - Wells Fargo

A.J. Rice - Credit Suisse

Nathan Rich - Goldman Sachs

Kevin Fischbeck - Bank of America

Michael Hall - Morgan Stanley

George Hill - Deutsche Bank

Steven Valiquette - Barclays

Operator

Good day and welcome to the Molina Healthcare Second Quarter 2022 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Joe Krocheski, Senior Vice President of Investor Relations. Please go ahead.

Joe Krocheski

Good morning and welcome to Molina Healthcare’s second quarter 2022 earnings call. Joining me today are Molina’s President and CEO, Joe Zubretsky; and our CFO, Mark Keim.

A press release announcing our second quarter earnings was distributed after the market closed yesterday and is available on our Investor Relations website. Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release. For those who listen to the rebroadcast of this presentation, we remind you that the remarks made are as of today, Thursday, July 28, 2022 and have not been updated subsequent to the initial earnings call.

In this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures can be found in our second quarter 2022 press release. During our call, we will be making certain forward-looking statements, including, but not limited to, statements regarding our 2022 guidance, our 2023 outlook, our growth strategy and expected growth, our RFP submissions, the COVID-19 pandemic, our acquisitions, our future margins and embedded earnings power and our long-term outlook.

Listeners are cautioned that all of our forward-looking statements are subject to certain risks and uncertainties that can cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors discussed in our Form 10-K annual report filed with the SEC as well as the risk factors listed in our Form 10-Q and Form 8-K filings with the SEC. After the completion of our prepared remarks, we will open the call to take your questions.